Artivion (AORT) vs Integra LifeSciences (IART)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Integra LifeSciences (IART) has outperformed Artivion (AORT) over the past year, losing 9.5% versus a loss of 48.3%. Over five years, AORT leads with a -0.7% price change compared with -80.2% for IART. Integra LifeSciences is the larger company by market cap ($1.04 billion vs $1.03 billion), about 1.0 times the size.
On valuation, Integra LifeSciences trades at a lower forward P/E (5.2x vs 28.3x for Artivion).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | IART |
|---|---|---|
| Share price | $21.21 | $13.41 |
| Market cap | $1.03B | $1.04B |
| 1-day change | -1.85% | +3.15% |
| YTD return | -53.50% | +7.97% |
| 1-year return | -48.26% | -9.45% |
| 5-year return | -0.70% | -80.19% |
| Forward P/E | 28.34 | 5.16 |
| EPS (TTM) | $-0.07 | $-0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.25 | $20.49 |
| 52-week low | $19.16 | $8.70 |
| Distance from 52-week high | -56.04% | -34.55% |
| Analyst consensus | none | hold |
| Avg. price target upside | +98.73% | +37.06% |
| Average volume | 637.38K | 916.55K |
| Shares outstanding | 48.76M | 77.77M |
| Employees | 1,800 | 4,427 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IART has outperformed AORT by 38.8 percentage points over the past year.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Health Care · Medical/Dental Instruments · 1,800 employees
About Integra LifeSciences
IART stock →Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Health Care · Medical/Dental Instruments · 4,427 employees
AORT vs IART FAQ
Which is bigger, Artivion or Integra LifeSciences?
Integra LifeSciences (IART) is larger, with a market capitalization of $1.04B compared with $1.03B for Artivion (AORT).
Which stock has performed better over the past year, AORT or IART?
IART returned -9.45% over the past 12 months, compared with -48.26% for AORT (price return, excluding dividends). Past performance does not predict future results.
Are Artivion and Integra LifeSciences in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.